scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH · IEX Real-Time Price · USD
4.510
+0.090 (2.04%)
Apr 18, 2024, 4:00 PM EDT - Market closed
scPharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for scPharmaceuticals stock have an average target of 19.33, with a low estimate of 18 and a high estimate of 20. The average target predicts an increase of 328.60% from the current stock price of 4.51.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 14, 2024.
Analyst Ratings
The average analyst rating for SCPH stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +299.11% | Mar 14, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +343.46% | Sep 7, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +299.11% | Aug 11, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +299.11% | Aug 2, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +299.11% | Jul 19, 2023 |
Financial Forecast
Revenue This Year
40.81M
from 13.59M
Increased by 200.22%
Revenue Next Year
99.70M
from 40.81M
Increased by 144.31%
EPS This Year
-1.51
from -1.42
EPS Next Year
-0.63
from -1.51
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 47.9M | 141.4M | 269.6M | 262.5M | 349.9M |
| Avg | 40.8M | 99.7M | 188.5M | 251.5M | 334.4M |
| Low | 35.8M | 80.3M | 145.3M | 239.8M | 313.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 252.2% | 246.6% | 170.4% | 39.2% | 39.1% |
| Avg | 200.2% | 144.3% | 89.1% | 33.4% | 33.0% |
| Low | 163.4% | 96.7% | 45.8% | 27.2% | 24.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.37 | -0.27 | 1.70 | 3.37 | 5.32 |
| Avg | -1.51 | -0.63 | 0.91 | 2.70 | 4.02 |
| Low | -1.71 | -1.13 | 0.08 | 2.25 | 2.84 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 268.8% | 97.2% |
| Avg | - | - | - | 195.4% | 48.9% |
| Low | - | - | - | 146.6% | 5.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.